drugset / Trial / NCT02138773

A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects

NCT02138773

Phase 1 Completed 80 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to investigate the relative bioavailability of two types of prolonged release formulation of tamsulosin hydrochloride in Chinese healthy subjects. The safety of tamsulosin formulation is also compared.

Timeline

Start
2014-04
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamsulosin Other / unclassified Oral

Indications

No indication recorded.